Apollomics Inc

Biotech Stocks Healthcare Stocks

$14.51

-1.34 (-8.45%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target -14.6% upside

Low Target $7.78

Average Target $12.39

High Target $16.73

Current Price $14.51

Current
$14.51

Target
$12.39

$7.78 $12.39 avg $16.73

Scenario Analysis

Bear Case

$7.78

-46.4%

Low target

Base Case

$12.39

-14.6%

Avg target

Bull Case

$16.73

+15.3%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$42.12

-65.6% from high

52-Week Low

$3.66

+296.6% from low

Target vs 52W High

$12.39

-70.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%